With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing [Yahoo! Finance]
What Makes Vir Biotechnology (VIR) a New Buy Stock [Yahoo! Finance]
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors [Yahoo! Finance]
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 [Yahoo! Finance]